Regis Healthcare stock heads toward its November 17 AGM

Published on 10/08/2026 at 06:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Regis Healthcare stock heads toward its November 17 AGM after FY2026 revenue reached AUD 1.35 billion. Funding rose 2.55 percent from October 1.

Regis Healthcare, AU000000REG6, Illustration mit AI erstellt.

Regis Healthcare (ISIN AU000000REG6) was trading at AUD 4.33 on the ASX on October 8, 2026, at 3:29 p.m. AEDT, down 0.34 percent from the previous close. The next scheduled corporate checkpoint is the annual general meeting on November 17, 2026, according to FinScry.

AGM puts funding pressure on the agenda

The meeting follows a government funding adjustment that lifted the Australian National Aged Care Classification starting price by 2.55 percent to AUD 303.19 from October 1, 2026. The company said the increase trails cost inflation, while the hoteling supplement remained at AUD 22.15 per resident per day, as reported by Motley Fool on September 14, 2026.

That policy gap matters because Regis is trying to protect margins through room-price increases, higher everyday living fees and operating efficiencies. The November meeting therefore provides a dated point for investors to assess whether pricing actions are offsetting the funding and wage burden.

FY2026 growth provides the counterweight

Regis reported FY2026 revenue from services of AUD 1.35 billion, up 16 percent from FY2025, while underlying EBITDA rose 10 percent to AUD 138 million, according to Stocklight. Statutory net profit reached AUD 55.7 million, a 14 percent year-over-year increase.

The operating comparison is substantial: revenue growth exceeded EBITDA growth by 6 percentage points. That spread makes occupancy, labor costs and resident pricing important metrics for the AGM, rather than revenue growth alone.

Consensus target stays above the market

The published analyst consensus lists a Buy rating from six analysts and an average 12-month price target of AUD 6.075, according to Investing.com. Against the ASX price of AUD 4.33, that average target lies 40.3 percent above the price.

The market is applying a sharper test to the company than the consensus target alone suggests. Regis Healthcare's 52-week range is AUD 3.85 to AUD 8.20, placing the October 8 price AUD 4.87 below the yearly high and AUD 0.48 above the low.

Market value stands at AUD 1.3 billion

Regis Healthcare had a market capitalization of AUD 1.3 billion as of October 8, 2026. The ASX quote therefore combines a modest intraday decline with a valuation picture shaped by FY2026 earnings, government funding settings and the November 17 AGM.